Bio2Vec

BIO-KNOWLEDGE-GRAPH

A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method.

Impaired ristocetin cofactor assay activity

ID: HP:0030129

Type: http://bio2vec.net/ontology/phenotype

Label: Impaired ristocetin cofactor assay activity

Synonyms: Impaired ristocetin cofactor assay activity

Alternative IDs: als

API: GO

SPARQL: GO

Similar Entities

Impaired ristocetin cofactor assay activity

HP:0030129
Decreased level of histidine-rich glycoprotein

HP:0040227
Impaired ristocetin-induced platelet aggregation

HP:0011871
Enhanced ristocetin cofactor assay activity

HP:0030136
Impaired von Willibrand factor collagen binding activity

HP:0030130
Abnormality of von Willebrand factor

HP:0012146
Total absence von Willebrand factor multimers

HP:0030134
Increased plasma vitamin K epoxide after vitamin K supplementation

HP:0040239
Increased ratio of VWF propeptide to VWF antigen

HP:0040240
Reduced quantity of Von Willebrand factor

HP:0012147
Factor XIII subunit B deficiency

HP:0040234
Abnormal von Willebrand factor multimer distribution

HP:0030131
Decreased level of heparin co-factor II

HP:0040226
Decreased level of plasminogen

HP:0040228
Absence of large von Willibrand factor multimers

HP:0030132
Impaired binding of factor VIII to VWF

HP:0040237
Absence of intermediate von Willibrand factor multimers

HP:0030135
Reduced von Willebrand factor activity

HP:0008330
Decrease in high molecular weight von Willebrand factor Multimers

HP:0040225
Decreased level of tissue plasminogen activator

HP:0040230
Factor XIII subunit A deficiency

HP:0040233
Reduced factor VIII activity

HP:0003125
Reduced factor XIII activity

HP:0008357
Hyperfibrinogenemia

HP:0011899
Dysfibrinogenemia

HP:0011901
regulation of convergent extension involved in neural plate elongation

GO:1904130
catechol oxidase (dimerizing) activity

GO:0047731
Reduced antithrombin III activity

HP:0001976
Hyperfibrinolysis

HP:0040236
Decreased level of thrombomodulin

HP:0040229
Abnormal presence of ultra-large von Willebrand factor multimers

HP:0030133
Elevated factor V activity

HP:0011996
Abnormality of circulating fibrinogen

HP:0011898
Reduced prothrombin consumption

HP:0003337
Reduced factor IX activity

HP:0011858
Generalized neonatal hypotonia

HP:0008935
Reduced alpha-2-antiplasmin activity

HP:0040245
Reduced factor V activity

HP:0003225
Hypofibrinogenemia

HP:0011900
long-term strengthening of neuromuscular junction

GO:0042062
Impaired thrombin-induced platelet aggregation

HP:0011872
Abnormality of basophils

HP:0001912
Reduced factor XII activity

HP:0004841
Factor X activation deficiency

HP:0008354
Abnormality of fibrinolysis

HP:0040224
regulation of protein kinase D signaling

GO:1903570
Acute hepatic steatosis

HP:0006573
Resistance to activated protein C

HP:0012175
Abnormal muscle fiber gamma sarcoglycan

HP:0030104
Reduced euglobulin clot lysis time

HP:0040247
regulation of maintenance of mitotic sister chromatid cohesion

GO:2000718
positive regulation of oxidative phosphorylation uncoupler activity

GO:2000277
negative regulation of maintenance of mitotic sister chromatid cohesion

GO:2000719
obsolete hydrolase activity

GO:0016816
no_name

GO:0042519
positive regulation of rubidium ion transport

GO:2000682
regulation of monocyte antigen processing and presentation

GO:0002613
L-3-cyanoalanine synthase activity

GO:0050017
Abnormality of the distal tibial epiphysis

HP:0010592
recurrent extraskeletal chondrosarcoma

DOID:6268
Prolonged whole-blood clotting time

HP:0005542
Prolonged somatosensory evoked potentials

HP:0007104
corticospinal neuron axon decussation

GO:0021973
homing of group II introns

GO:0006315
neural crest cell differentiation involved in parathyroid gland development

GO:1902638
no_name

GO:0042526
mesenchymal cell differentiation involved in mammary gland development

GO:0060610
Pelvic girdle amyotrophy

HP:0008946
Abnormal muscle fiber lamin A/C

HP:0030123
regulation of starch biosynthetic process

GO:0010581
regulation of axial mesodermal cell fate specification

GO:0048328
Increased urinary copper concentration

HP:0010839
positive regulation of maintenance of meiotic sister chromatid cohesion

GO:2000711
Reduced prothrombin antigen

HP:0040250
Abnormal sialylation of N-linked protein glycosylation

HP:0012349
Reduced factor XI activity

HP:0001929
Prolonged euglobulin clot lysis time

HP:0040243
mitochondrial srRNA export from mitochondrion

GO:0019092
regulation of orcinol biosynthetic process

GO:1900701
transcription factor activity

GO:0001075
regulation of interleukin-19 biosynthetic process

GO:0045384
Univentricular heart with absent left sided atrioventricular connection

HP:0011549
Reduced prothrombin activity

HP:0012201
Decreased adipose tissue around neck

HP:0005995
positive regulation of DNA endoreduplication

GO:0032877
negative regulation of cell-glial cell adhesion involved in cerebral cortex lamination

GO:0021821
L-arabinonate dehydratase activity

GO:0050020
EEG with generalized slow activity grade 2

HP:0011207
Reduced plasminogen activator inhibitor 1 antigen

HP:0040249
N-methylcoclaurine 3'\''-monooxygenase activity

GO:0050593
obsolete cytoplasmic dynein light chain

GO:0001690
response to norepinephrine

GO:0071873
malignant neoplasm of nipple

DOID:6628
regulation of interleukin-11 production

GO:0032654
RNA polymerase II transcription factor activity

GO:0001202
regulation of B cell antigen processing and presentation

GO:0002622
positive regulation of glucuronoxylan catabolic process

GO:2000917
obsolete ubiquitin thiolesterase activity

GO:0004221
Decreased fucosylation of N-linked protein glycosylation

HP:0012353
R3/R4 cell fate commitment

GO:0007464

Neighbourhood Visualization